Novartis Pharmaceuticals Corporation v. HEC Pharm Co., Ltd. et al > Summary
Court Case Number 1:21-cv-01530
Filing Date Oct 27, 2021
Court Delaware District Court
Status Unknown
JudgesMaryellen Noreika, Gregory B. Williams, Jennifer L. Hall
Plaintiff
Defendant
Plaintiff Attorneys
6Novartis
Attorney Name: Alexandra M. Joyce
McCarter & English
Novartis
Attorney Name: Daniel M. Silver
McCarter & English
Novartis
Attorney Name: Jane M. Love
Gibson Dunn & Crutcher
Attorney Name: Robert W. Trenchard
Novartis
Attorney Name: Daniel M. Silver
McCarter & English
Novartis
Attorney Name: Alexandra M. Joyce
McCarter & English
Defendant Attorneys
16HEC Pharm Co., Ltd.
Attorney Name: Mieke K. Malmberg
Skiermont Derby
HEC Pharm Co., Ltd.
Attorney Name: Paul J. Skiermont
Skiermont Derby
HEC Pharm Co., Ltd.
Attorney Name: Sarah E. Spires
Skiermont Derby
HEC Pharm Co., Ltd.
Attorney Name: Stamatios Stamoulis
Stamoulis & Weinblatt
HEC Pharm Co., Ltd.
Attorney Name: Steve Udick
Skiermont Derby
Attorney Name: Steve Udick
HEC Pharm Co., Ltd.
Attorney Name: Mieke K. Malmberg
HEC Pharm Co., Ltd.
Attorney Name: Paul J. Skiermont
HEC Pharm Co., Ltd.
Attorney Name: Sarah E. Spires
HEC Pharm Co., Ltd.
Attorney Name: Stamatios Stamoulis
Stamoulis & Weinblatt
HEC Pharm Co., Ltd.
Attorney Name: Steve Udick
HEC Pharm Co., Ltd.
Attorney Name: Mieke K. Malmberg
HEC Pharm Co., Ltd.
Attorney Name: Paul J. Skiermont
HEC Pharm Co., Ltd.
Attorney Name: Sarah E. Spires
HEC Pharm Co., Ltd.
Attorney Name: Stamatios Stamoulis
Stamoulis & Weinblatt
HEC Pharm Co., Ltd.
Attorney Name: Steve Udick
Cause
35:1 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10543179 | Dosage regimen of an S1P receptor modulator | Jan 28, 2020 |
| 09187405 | S1P receptor modulators for treating relasping-remitting multiple sclerosis | Nov 17, 2015 |
